Ativo Capital Management’s Labcorp LH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q3
Sell
-6,055
Closed -$1.22M 94
2022
Q2
$1.22M Buy
6,055
+5
+0.1% +$1.07K 0.82% 41
2022
Q1
$1.37M Buy
6,050
+1
+0% +$235 0.7% 69
2021
Q4
$1.63M Sell
6,049
-3
-0% -$743 0.72% 63
2021
Q3
$1.46M Hold
6,052
0.69% 59
2021
Q2
$1.43M Hold
6,052
0.61% 71
2021
Q1
$1.33M Buy
6,052
+47
+0.8% +$9.43K 0.56% 69
2020
Q4
$1.05M Buy
6,005
+14
+0.2% +$2.42K 0.45% 96
2020
Q3
$969K Sell
5,991
-489
-8% -$77.5K 0.47% 86
2020
Q2
$925K Buy
6,480
+1
+0% +$138 0.5% 87
2020
Q1
$703K Buy
6,479
+1
+0% +$144 0.44% 88
2019
Q4
$941K Sell
6,478
-63
-1% -$9.1K 0.43% 88
2019
Q3
$944K Hold
6,541
0.46% 90
2019
Q2
$972K Sell
6,541
-1,623
-20% -$226K 0.44% 88
2019
Q1
$1.07M Sell
8,164
-6,421
-44% -$791K 0.45% 92
2018
Q4
$1.58M Sell
14,585
-2,263
-13% -$303K 0.74% 46
2018
Q3
$2.51M Sell
16,848
-74
-0.4% -$11.3K 0.67% 29
2018
Q2
$2.61M Sell
16,922
-466
-3% -$70.3K 0.73% 23
2018
Q1
$2.42M Buy
+17,388
New +$2.55M 0.69% 32

Other funds holding LH

Ativo Capital Management's LH Position: Q3 2022 in Review

Ativo Capital Management sold out of Labcorp (LH) in Q3 2022, closing a stake of 6,055 shares — an estimated $1.22M sold.

Ativo Capital Management first reported a position in LH in Q1 2018 and held it in 18 quarters. The position peaked at $2.61M in Q2 2018. 936 funds tracked by Wall St. Rank hold LH as of Q3 2022.

  • Ativo Capital Management reported no remaining Labcorp position as of Q3 2022 after selling out during the quarter.
  • Ativo Capital Management sold 6,055 Labcorp shares in Q3 2022, an estimated $1.22M.
  • Ativo Capital Management first reported a position in Labcorp in Q1 2018 and held it in 18 quarters.
  • Ativo Capital Management's Labcorp position peaked at $2.61M in Q2 2018.
  • 936 funds tracked by Wall St. Rank held Labcorp as of Q3 2022.

Based on Ativo Capital Management's 13F filing for Q3 2022, filed 14 Nov 2022.